KR0169118B1 - 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물 - Google Patents

치료에 유용한 혈소판 항-응집 효과를 갖는 조성물 Download PDF

Info

Publication number
KR0169118B1
KR0169118B1 KR1019900702419A KR900702419A KR0169118B1 KR 0169118 B1 KR0169118 B1 KR 0169118B1 KR 1019900702419 A KR1019900702419 A KR 1019900702419A KR 900702419 A KR900702419 A KR 900702419A KR 0169118 B1 KR0169118 B1 KR 0169118B1
Authority
KR
South Korea
Prior art keywords
taurine
acetylsalicylic acid
treatment
compositions
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019900702419A
Other languages
English (en)
Korean (ko)
Other versions
KR920700037A (ko
Inventor
제슈 코바흐비아
Original Assignee
찰스 에반스 맥파르랑
나티벨르(쏘시에떼 아노님)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 찰스 에반스 맥파르랑, 나티벨르(쏘시에떼 아노님) filed Critical 찰스 에반스 맥파르랑
Publication of KR920700037A publication Critical patent/KR920700037A/ko
Application granted granted Critical
Publication of KR0169118B1 publication Critical patent/KR0169118B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019900702419A 1989-03-10 1990-03-06 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물 Expired - Fee Related KR0169118B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8903138A FR2644061A1 (fr) 1989-03-10 1989-03-10 Composition a activite antiagregante plaquettaire utilisable en therapeutique
FR89/03138 1989-03-10
PCT/FR1990/000149 WO1990010447A1 (fr) 1989-03-10 1990-03-06 Composition a activite anti-agregante plaquettaire utilisable en therapeutique

Publications (2)

Publication Number Publication Date
KR920700037A KR920700037A (ko) 1992-02-19
KR0169118B1 true KR0169118B1 (ko) 1999-01-15

Family

ID=9379557

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900702419A Expired - Fee Related KR0169118B1 (ko) 1989-03-10 1990-03-06 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물

Country Status (10)

Country Link
EP (1) EP0387140B1 (enExample)
JP (1) JP2935138B2 (enExample)
KR (1) KR0169118B1 (enExample)
AT (1) ATE106733T1 (enExample)
CA (1) CA2027593C (enExample)
DE (1) DE69009538T2 (enExample)
ES (1) ES2058832T3 (enExample)
FR (1) FR2644061A1 (enExample)
MX (1) MX174250B (enExample)
WO (1) WO1990010447A1 (enExample)

Also Published As

Publication number Publication date
MX174250B (es) 1994-05-02
EP0387140B1 (fr) 1994-06-08
CA2027593A1 (fr) 1990-09-11
WO1990010447A1 (fr) 1990-09-20
JPH03504509A (ja) 1991-10-03
KR920700037A (ko) 1992-02-19
FR2644061A1 (fr) 1990-09-14
ES2058832T3 (es) 1994-11-01
EP0387140A1 (fr) 1990-09-12
DE69009538D1 (de) 1994-07-14
CA2027593C (fr) 2001-01-02
DE69009538T2 (de) 1995-01-12
JP2935138B2 (ja) 1999-08-16
ATE106733T1 (de) 1994-06-15
FR2644061B1 (enExample) 1994-04-22

Similar Documents

Publication Publication Date Title
US3795739A (en) Treatment of parkinson disease
JP2703906B2 (ja) 酸化に対して安定化された薬剤組成物
JP3388117B2 (ja) カイガンショウ抽出物に基づく血小板反応性調節剤の調製方法
SK286523B6 (sk) Použitie zmesi esenciálnych mastných kyselín obsahujúcej etylester kyseliny eikozapentaénovej a etylesteru kyseliny dokozahexaénovej na prípravu lieku na prevenciu úmrtia pacienta, ktorý prekonal infarkt myokardu
KR20080024511A (ko) 심혈관 이벤트 발병 예방용 조성물
US12036198B2 (en) Dosage forms and therapeutic uses of L-4-chlorokynurenine
JP3370795B2 (ja) 高血圧の予防薬
JPS62185014A (ja) 複合調剤薬
US4794112A (en) Acetaminophen/hydroxyzine analgesic combinations
JPH0352815A (ja) 血管内血液凝固症候群の治療剤
KR0169118B1 (ko) 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물
ES2237625T3 (es) Uso de un derivado de hidantoina en una composicion farmaceutica contra la hipoalbuminemia.
JPS6229525A (ja) デイルチアゼムおよびアスピリンを主成分とする血小板凝集阻害剤
US3197370A (en) Pyrilamine tannate compositions
JP2002505678A (ja) 腫瘍組織を選択的に制御するための、相乗効果を有する組成物
IE71022B1 (en) Stabilizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamides containing preparation and stabilizing method therefor
Nagakawa et al. Effect of the combination of antiplatelet agents in man: combination of aspirin, trapidil, ticlopidine and dipyridamole
EA003055B1 (ru) Способ лечения легочной гипертензии
JPS6248622A (ja) 癌転移抑制剤
RU2150273C1 (ru) Антигипоксическое и актопротекторное средство
JPS63501360A (ja) 血栓性および血栓塞栓性疾患の治療のためのプロスタサイクリン、その類縁体またはプロスタグランジンおよびトロンボキサン類縁体
JPH09227371A (ja) 粥状動脈硬化抑制剤
US3172809A (en) Medicinal compositions having an antalgic action
RU2200550C2 (ru) Новые лекарственные формы димоцифона в терапии лепры, зудящих и аллергодерматозов, герпетиформного дерматита дюринга
US3849570A (en) Method of treating cardiac arrhythmia with 2-(2'-diethylaminoethyl)-3-phenyl-phthalimidine and its salts

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20011010

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20011010

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000